PlainRecalls
FDA Drug Moderate Class II Terminated

Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx Only, 30 Capsules per Bottle, Manufactured in Israel by: Teva Pharmaceutical IND, LTD, Jerusalem, Israel, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA, 18960, NDC 0093-7543-56

Reported: April 9, 2014 Initiated: March 4, 2014 #D-1183-2014

Product Description

Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx Only, 30 Capsules per Bottle, Manufactured in Israel by: Teva Pharmaceutical IND, LTD, Jerusalem, Israel, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA, 18960, NDC 0093-7543-56

Reason for Recall

Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg & 60 mg due to a customer complaint trend regarding capsule breakage.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
598,033 Bottles
Distribution
Nationwide, Guam, Puerto Rico, American Samoa, Virgin Islands.
Location
Horsham, PA

Frequently Asked Questions

What product was recalled?
Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx Only, 30 Capsules per Bottle, Manufactured in Israel by: Teva Pharmaceutical IND, LTD, Jerusalem, Israel, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA, 18960, NDC 0093-7543-56. Recalled by Teva Pharmaceuticals USA. Units affected: 598,033 Bottles.
Why was this product recalled?
Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg & 60 mg due to a customer complaint trend regarding capsule breakage.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 9, 2014. Severity: Moderate. Recall number: D-1183-2014.